About us

We are the UK’s largest dedicated funder of breast cancer research. Our achievements include opening the UK’s first dedicated breast cancer research centre at the Institute of Cancer Research in London, launching the world’s largest and most comprehensive study into the causes of breast cancer and establishing the UK’s first ever national breast cancer tissue bank, to provide researchers across the UK and Ireland with tissue vital to their work.

We fund cutting-edge science, supporting the brightest and best scientists and projects at the right time and in the right way. By maximising collaboration and championing innovation, including our Breast Cancer Now Catalyst Programme with Pfizer, we are building a global scientific community focused on addressing the critical gaps in breast cancer knowledge and research.

By championing PhD students and scientists at the start of their careers, we’ll invest in the future of breast cancer research while maintaining our strong links with established thought leaders and clinical experts.

The end result is that more women will benefit from our research, faster.

Response mode funding

We will fund research at any research institution in the UK and Ireland and offer funding for the following types of grants:

Applications are reviewed by our Grants Committee who advise the charity what to fund.

Long-term programme grant funding

Our long-term programme funding includes Breast Cancer Now's research centre at the Institute of Cancer Research and a research unit in King’s College London which focuses on triple negative breast cancer. 

We also fund the Generations Study, the world’s largest and most comprehensive scientific study into the causes of breast cancer, following more than 113,000 women across the UK. 

Breast Cancer Now’s governance structure is designed to ensure that the funding decisions made by the Board of Trustees are informed by sound and independent advice from national and international expert scientists and clinicians. 

All our new research funding undergoes thorough peer-review, performed by independent, active experts from around the world. Our peer-review process follows best-practice guidelines, as required by our membership of the Association of Medical Research Charities (AMRC) and the National Cancer Research Institute (NCRI) and for our funding to meet the regulations of the Charity Research Support Fund (CSRF).

Find out about Breast Cancer Now's strict Conflict of interest policy.

Open access

We believe that if we all act now, by 2050, everyone who develops breast cancer will live. We will do this by finding ways to prevent the disease, improving early diagnosis and developing new treatments for all types of breast cancer.

We believe this can be achieved faster by making our research open and freely available to everyone.

For more information please refer to our Breast Cancer Now open access policy.  

Read all of our research policies.